Bank of New York Mellon’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,290
| Closed | -$9.5K | – | 4412 |
|
|
2023
Q2 | $9.5K | Sell |
10,290
-719
| -7% | -$664 | ﹤0.01% | 4336 |
|
|
2023
Q1 | $8.35K | Hold |
11,009
| – | – | ﹤0.01% | 4361 |
|
|
2022
Q4 | $27.6K | Sell |
11,009
-66
| -0.6% | -$166 | ﹤0.01% | 4313 |
|
|
2022
Q3 | $15K | Hold |
11,075
| – | – | ﹤0.01% | 4476 |
|
|
2022
Q2 | $14K | Sell |
11,075
-58
| -0.5% | -$73 | ﹤0.01% | 4524 |
|
|
2022
Q1 | $32K | Hold |
11,133
| – | – | ﹤0.01% | 4577 |
|
|
2021
Q4 | $25K | Hold |
11,133
| – | – | ﹤0.01% | 4572 |
|
|
2021
Q3 | $29K | Hold |
11,133
| – | – | ﹤0.01% | 4481 |
|
|
2021
Q2 | $32K | Sell |
11,133
-1,573
| -12% | -$4.52K | ﹤0.01% | 4362 |
|
|
2021
Q1 | $40K | Sell |
12,706
-1,020
| -7% | -$3.21K | ﹤0.01% | 4284 |
|
|
2020
Q4 | $36K | Hold |
13,726
| – | – | ﹤0.01% | 4173 |
|
|
2020
Q3 | $40K | Hold |
13,726
| – | – | ﹤0.01% | 4037 |
|
|
2020
Q2 | $47K | Sell |
13,726
-7,753
| -36% | -$26.5K | ﹤0.01% | 3991 |
|
|
2020
Q1 | $43K | Buy |
21,479
+10,721
| +100% | +$21.5K | ﹤0.01% | 3982 |
|
|
2019
Q4 | $43K | Buy |
10,758
+605
| +6% | +$2.42K | ﹤0.01% | 4121 |
|
|
2019
Q3 | $32K | Sell |
10,153
-621
| -6% | -$1.96K | ﹤0.01% | 4144 |
|
|
2019
Q2 | $42K | Buy |
+10,774
| New | +$42K | ﹤0.01% | 4127 |
|
|
2017
Q3 | – | Sell |
-1,901
| Closed | -$13K | – | 4317 |
|
|
2017
Q2 | $13K | Buy |
+1,901
| New | +$13K | ﹤0.01% | 4256 |
|